# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-018675
Filing Date
2021-08-05
Accepted
2021-08-05 08:01:17
Documents
63
Period of Report
2021-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1439764
2 |  | ex31-1.htm | EX-31.1 | 17534
3 |  | ex31-2.htm | EX-31.2 | 17530
4 |  | ex32-1.htm | EX-32.1 | 4796
5 |  | ex32-2.htm | EX-32.2 | 5334
| Complete submission text file | 0001493152-21-018675.txt |  | 5296357

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | lpcn-20210630.xsd | EX-101.SCH | 35181
7 | XBRL CALCULATION FILE | lpcn-20210630_cal.xml | EX-101.CAL | 49569
8 | XBRL DEFINITION FILE | lpcn-20210630_def.xml | EX-101.DEF | 152414
9 | XBRL LABEL FILE | lpcn-20210630_lab.xml | EX-101.LAB | 324385
10 | XBRL PRESENTATION FILE | lpcn-20210630_pre.xml | EX-101.PRE | 257473
11 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 698101

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36357 | Film No.: 211146397
SIC: 2834 Pharmaceutical Preparations